Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TS-23 by Translational Sciences for Acute Ischemic Stroke: Likelihood of Approval
TS-23 is under clinical development by Translational Sciences and currently in Phase II for Acute Ischemic Stroke. According to GlobalData,...